As a sponsor of the 4th Dutch Antisense Therapeutics Symposium, Synoligo reaffirms its commitment to advancing oligonucleotide innovation. Representing us at the symposium, Dr. John Randolph will engage with fellow experts to explore emerging strategies and share how Synoligo’s manufacturing capabilities can support cutting-edge research across the Netherlands.